MIRA: Probing Glycan Polymer Patterns on Bacterial Cell Surfaces
MIRA:探测细菌细胞表面的聚糖聚合物模式
基本信息
- 批准号:10668330
- 负责人:
- 金额:$ 34.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary/Abstract
Our planet is inhabited by trillions of bacteria that live inside and outside of humans. The “skin”, or
surface, of bacteria is called the cell envelope, and functions to separate us from them. Although some bacteria
are symbionts, infection by pathogenic bacteria is still a major cause of death worldwide. While Gram-negative
bacteria contain a protective outer membrane layer absent in most Gram-positives, almost all bacteria contain
polymers composed of unique patterns of glycans that extend from the cell surface. Bacterial surface sugar
polymers, or exo-polysaccharides, act as molecular barcodes that distinguish different strains of bacteria within
a single species. Many bacterial exo-polysaccharides contain rare sugars, which are monosaccharides that are
absent in other organisms, including humans. While exo-polysaccharides are necessary for host infection, we
still lack an understanding of how rare sugar-containing glycan polymers are assembled, recognized, and enable
survival in the host.
My laboratory seeks to generate chemical and biochemical tools to study bacterial protein and glycan
pathways that enable survival in different environments. Our main areas of focus are: (1) development of small
molecule regulators of bacterial chaperone function; (2) manipulation of cell surface sugar patterns to selectively
label and disable bacteria. This proposal focuses on the latter program, in which we identify rare saccharide
subunits that are unique to Gram-negative cell surface polymers called O-antigens, and represent key epitopes
that mediate interactions with hosts and susceptibility to antibiotics. Over the next five years, we will address the
following questions: (1) Can we improve chemoenzymatic routes to rare sugar precursor substrates? (2) How
do glycosyltransferases recognize rare sugar substrates to build O-antigens? (3) Are O-antigen
glycosyltransferases regulated via protein-protein interactions? (4) What host protein structural motifs are
involved in bacterial rare sugar recognition? (5) Can we identify new host proteins involved in bacterial
recognition? To answer these questions, we will use a multidisciplinary approach, involving a combination of
organic chemistry, chemical biology, biochemistry, microbiology and sequencing-based analyses. This work will
significantly expand our understanding of cellular mechanisms underlying bacterial polysaccharide synthesis,
and will teach us how humans recognize foreign sugars.
Relevance to public health: In addition to providing fundamental insight into the production of bacterial factors
that are important for infection, the results of this proposal will inform novel strategies to disable hard-to-treat
Gram-negative infections by interference of essential host-pathogen interactions, as well as biomolecular
reagents to recognize bacterial oligosaccharide structures for new diagnostics.
项目摘要/摘要
我们的星球受到人类内外的数万亿个细菌的影响。 “皮肤”或
细菌的表面称为细胞包膜,功能可将其与它们分开。虽然有些细菌
是符号,致病细菌感染仍然是全球死亡的主要原因。而革兰氏阴性
细菌在大多数革兰氏阳性中都没有受保护的外膜层,几乎所有细菌都包含
聚合物由从细胞表面延伸的聚糖的独特模式组成。细菌表面糖
聚合物或外部 - 丙糖浆充当分子条形码,区分不同的细菌菌株
一个物种。许多细菌外的外糖浆含有稀有糖,这是单糖的
在包括人类在内的其他生物体中不存在。虽然宿主感染是必需的,但我们
仍然缺乏了解少于少量含糖的聚糖聚合物组装,识别和启用的理解
主持人的生存。
我的实验室试图生成化学和生化工具来研究细菌蛋白和聚糖
可以在不同环境中生存的途径。我们的主要重点领域是:(1)开发小型
细菌链酮功能的分子调节剂; (2)操纵细胞表面糖图案以选择性
标签和禁用细菌。该提案重点介绍了后一个计划,我们在其中确定了稀有的2糖
革兰氏阴性细胞表面聚合物称为O-抗原的亚基,代表关键表位
介导与宿主的相互作用和对抗生素的敏感性。在接下来的五年中,我们将解决
以下问题:(1)我们可以改善稀有糖前体底物的化学酶途径吗? (2)如何
糖基转移酶是否识别稀有的糖基质来构建O-抗原? (3)是O-抗原
通过蛋白质 - 蛋白质相互作用调节的糖基转移酶? (4)哪种宿主蛋白结构基序是
参与细菌稀有糖识别? (5)我们可以识别涉及细菌的新宿主蛋白
认出?为了回答这些问题,我们将使用多学科的方法,涉及
有机化学,化学生物学,生物化学,微生物学和基于测序的分析。这项工作将
显着扩展我们对细菌多糖合成的细胞机制的理解,
并将教会我们人类如何识别外国糖。
与公共卫生有关:除了提供细菌工厂生产的基本见解
对于感染很重要,该提案的结果将为您提供新的策略,以禁用难以治疗
革兰氏阴性感染通过干扰必需的宿主 - 病原体相互作用以及生物分子
识别用于新诊断的细菌寡糖结构的试剂。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Preference of Bacterial Rhamnosyltransferases for 6-Deoxysugars Reveals a Strategy To Deplete O-Antigens.
- DOI:10.1021/jacs.3c03005
- 发表时间:2023-07-26
- 期刊:
- 影响因子:15
- 作者:Harnagel, Alexa P.;Sheshova, Mia;Zheng, Meng;Zheng, Maggie;Skorupinska-Tudek, Karolina;Swiezewska, Ewa;Lupoli, Tania J.
- 通讯作者:Lupoli, Tania J.
Expanding the Substrate Scope of a Bacterial Nucleotidyltransferase via Allosteric Mutations.
- DOI:10.1021/acsinfecdis.2c00402
- 发表时间:2022-10-14
- 期刊:
- 影响因子:5.3
- 作者:Zheng, Maggie;Zheng, Meng;Lupoli, Tania J.
- 通讯作者:Lupoli, Tania J.
共 2 条
- 1
Tania Lupoli的其他基金
MIRA: Probing Glycan Polymer Patterns on Bacterial Cell Surfaces
MIRA:探测细菌细胞表面的聚糖聚合物模式
- 批准号:1027591110275911
- 财政年份:2021
- 资助金额:$ 34.22万$ 34.22万
- 项目类别:
MIRA: Probing Glycan Polymer Patterns on Bacterial Cell Surfaces
MIRA:探测细菌细胞表面的聚糖聚合物模式
- 批准号:1045950010459500
- 财政年份:2021
- 资助金额:$ 34.22万$ 34.22万
- 项目类别:
Probing Glycan Polymer Patterns on Bacterial Cell Surfaces
探测细菌细胞表面的聚糖聚合物模式
- 批准号:1060738010607380
- 财政年份:2021
- 资助金额:$ 34.22万$ 34.22万
- 项目类别:
相似国自然基金
跨区域调水工程与区域经济增长:效应测度、机制探究与政策建议
- 批准号:72373114
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
农产品区域公用品牌地方政府干预机制与政策优化研究
- 批准号:72373068
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
新型城镇化与区域协调发展的机制与治理体系研究
- 批准号:72334006
- 批准年份:2023
- 资助金额:167 万元
- 项目类别:重点项目
我国西南地区节点城市在次区域跨国城市网络中的地位、功能和能级提升研究
- 批准号:72364037
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
多时序CT联合多区域数字病理早期预测胃癌新辅助化疗抵抗的研究
- 批准号:82360345
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Bacterial metabolism of catechol-O-methyltransferase inhibitors alters drug efficacy and toxicity
儿茶酚-O-甲基转移酶抑制剂的细菌代谢改变药物疗效和毒性
- 批准号:1060618410606184
- 财政年份:2023
- 资助金额:$ 34.22万$ 34.22万
- 项目类别:
On Demand Dissoluble Supramolecular Hydrogels: Towards Pain Free Burn Dressings
按需可溶性超分子水凝胶:迈向无痛烧伤敷料
- 批准号:1065822010658220
- 财政年份:2023
- 资助金额:$ 34.22万$ 34.22万
- 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:1064598910645989
- 财政年份:2023
- 资助金额:$ 34.22万$ 34.22万
- 项目类别:
Determining the molecular basis of gene silencing by MucR and defining its role in Brucella virulence
确定 MucR 基因沉默的分子基础并确定其在布鲁氏菌毒力中的作用
- 批准号:1073260510732605
- 财政年份:2023
- 资助金额:$ 34.22万$ 34.22万
- 项目类别:
A novel electric current-based treatment system for chronic wound biofilm infections
一种新型的基于电流的慢性伤口生物膜感染治疗系统
- 批准号:1072019110720191
- 财政年份:2023
- 资助金额:$ 34.22万$ 34.22万
- 项目类别: